FDA India boss quits
This article was originally published in Scrip
Executive Summary
The unexpected exit of Dr Altaf Ahmed Lal, director of the US FDA's India office, has raised many questions, though pharma industry bigwigs are optimistic that the agency's recent efforts to improve US-India co-operation in the area of drugs quality would stay on course.